Ampio

Ampio Pharma craters on FDA setback but plans to fight back

The FDA has asked Ampio Pharma to conduct another clinical trial for its osteoarthritis med, Ampion, setting back its BLA.

Amirah Al Idrus Aug 9, 2018 11:05am

After 2 share-crushing flops, Ampio claims phase 3 success

Dec 14, 2017 8:51am

Ampio shares in retreat on second failed osteoarthritis PhIII

Jul 1, 2016 5:51am

Ampio routed as lead osteoarthritis drug flunks a PhIII test

Apr 20, 2015 10:10am